{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:19:28Z","timestamp":1780373968931,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","award":["UL1TR004419"],"award-info":[{"award-number":["UL1TR004419"]}],"id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002200","name":"Robert Mapplethorpe Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016016","name":"Gilead UK and Ireland Corporate Contributions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jemermed.2025.03.001","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T21:56:04Z","timestamp":1742421364000},"page":"278-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A Randomized Controlled Trial of HIV Pre-Exposure Prophylaxis Provision in the Emergency Department (PrEPPED)"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7276-0549","authenticated-orcid":false,"given":"Ethan","family":"Cowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Eiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"O'Brien-Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2025.03.001_bib0001","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0002","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0003","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0004","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review","volume":"37","author":"Mayer","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0005","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.annepidem.2018.05.006","article-title":"Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States","volume":"28","author":"Siegler","year":"2018","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0006","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.2105\/AJPH.2016.303339","article-title":"Disparities in uptake of HIV preexposure prophylaxis in a large integrated health care system","volume":"106","author":"Marcus","year":"2016","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0008","first-page":"178","article-title":"What incentives are effective rewards for 'hidden populations' interviewed as a part of research projects?","volume":"110","author":"Cottler","year":"1995","journal-title":"Public Health Rep"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0009","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/emermed-2012-201934","article-title":"Cross-sectional study of the characteristics, healthcare usage, morbidity and mortality of injecting drug users attending an inner city emergency department","volume":"31","author":"O'Connor","year":"2014","journal-title":"Emerg Med J"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/jama.2010.1112","article-title":"Trends and characteristics of US emergency department visits, 1997\u20132007","volume":"304","author":"Tang","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0011","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ypmed.2017.04.028","article-title":"An increase in sexually transmitted infections seen in US emergency departments","volume":"100","author":"Pearson","year":"2017","journal-title":"Prev Med"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0012","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1360-0443.2007.02072.x","article-title":"Systematic review and meta-analyses of strategies targeting alcohol problems in emergency departments: interventions reduce alcohol-related injuries","volume":"103","author":"Havard","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0013","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.annemergmed.2012.02.006","article-title":"A brief intervention reduces hazardous and harmful drinking in emergency department patients","volume":"60","author":"D'onofrio","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0014","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/apc.2007.0157","article-title":"Nonoccupational postexposure prophylaxis for exposure to HIV in New York State emergency departments","volume":"22","author":"Ende","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/2325957414553847","article-title":"Nonoccupational post-exposure prophylaxis for HIV in New York State Emergency Departments","volume":"13","author":"Fitzpatrick","year":"2014","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0016","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/emp2.12295","article-title":"Utilizing emergency departments for pre-exposure Prophylaxis (prep)","volume":"1","author":"Shull","year":"2020","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0017","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/QAI.0000000000001890","article-title":"Comfort discussing HIV pre-exposure prophylaxis with patients among physicians in an urban emergency department","volume":"80","author":"Tortelli","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0018","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.annemergmed.2022.07.015","article-title":"HIV pre-exposure prophylaxis in the emergency department: a systematic review","volume":"81","author":"Gormley","year":"2023","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0019","unstructured":"HIV.gov. EHE Priority Juridictions. Available at: https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/jurisdictions. Accessed March 28, 2025."},{"key":"10.1016\/j.jemermed.2025.03.001_bib0020","series-title":"New York City Department of Health and Mental Hygiene. HIV Surveillance Annual Report, 2022","year":"2023"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0021","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0976-500X.72352","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"1","author":"Schulz","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0022","unstructured":"ICAP screener. Available at: https:\/\/icap-aws-bucket.s3.amazonaws.com\/icapcolumbiau\/wp-content\/uploads\/1_PrEP_Screening_for_Substantial_Risk_and_Eligibility_2.7.17.pdf. Accessed March 28, 2025."},{"key":"10.1016\/j.jemermed.2025.03.001_bib0023","series-title":"PrEP to prevent HIV and promote sexual health [Internet]","author":"Vail","year":"2022"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0024","doi-asserted-by":"crossref","first-page":"ofz310","DOI":"10.1093\/ofid\/ofz310","article-title":"Same-day HIV pre-exposure prophylaxis (PrEP) initiation during drop-in sexually transmitted diseases clinic appointments is a highly acceptable, feasible, and safe model that engages individuals at risk for HIV into PrEP care","volume":"6","author":"Kamis","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0025","series-title":"Conference on Retroviruses and Opportunistic Infections","article-title":"Immediate PrEP initiation at New York City sexual health clinics","author":"Mikati","year":"2019"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0026","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jemermed.2020.09.034","article-title":"Nontargeted hepatitis C screening in an urban emergency department in New York City","volume":"60","author":"Cowan","year":"2021","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0027","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/15381501.2019.1596861","article-title":"The attitudes toward pre-exposure prophylaxis (PrEP) scale: development and validation","volume":"18","author":"Jaspal","year":"2019","journal-title":"J HIV AIDS Soc Serv"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0028","unstructured":"RAND Health Care. Visit-Specific Satisfaction Instrument (VSQ-9). Available at: https:\/\/www.rand.org\/health-care\/surveys_tools\/vsq9.html. Accessed March 28, 2025."},{"key":"10.1016\/j.jemermed.2025.03.001_bib0029","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10461-012-0326-7","article-title":"Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV","volume":"17","author":"Feldman","year":"2013","journal-title":"AIDS Behav"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0031","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00131746-200603000-00002","article-title":"Nierenberg AA: STARD Investigators. Self-rated global measure of the frequency, intensity, and burden of side effects","volume":"12","author":"Wisniewski","year":"2006","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0033","unstructured":"Centers for Disease Control and Prevention: US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 Update: a clinical practice guideline. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/112360. Accessed March 28, 2025."},{"key":"10.1016\/j.jemermed.2025.03.001_bib0034","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/apc.2018.0011","article-title":"Which patients in the emergency department should receive preexposure prophylaxis? Implementation of a predictive analytics approach","volume":"32","author":"Ridgway","year":"2018","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajem.2021.04.087","article-title":"Estimated proportion of an urban academic emergency department patient population eligible for HIV preexposure prophylaxis","volume":"48","author":"Faryar","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0036","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/apc.2021.0012","article-title":"HIV risk and pre-exposure prophylaxis eligibility among emergency department patients","volume":"35","author":"Haukoos","year":"2021","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0037","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1089\/apc.2020.0228","article-title":"Targeted screening for HIV pre-exposure prophylaxis eligibility in two emergency departments in Washington, DC","volume":"34","author":"Kulie","year":"2020","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0038","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajem.2022.01.038","article-title":"Linking emergency department patients at risk for human immunodeficiency virus to pre-exposure prophylaxis","volume":"54","author":"Mahal","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0039","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/QAD.0000000000001385","article-title":"Defining the HIV pre-exposure prophylaxis care continuum","volume":"31","author":"Nunn","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0040","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/acem.14054","article-title":"Emergency department\u2013initiated interventions for patients with opioid use disorder: a systematic review","volume":"27","author":"Kaczorowski","year":"2020","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0041","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10461-016-1627-z","article-title":"Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature","volume":"21","author":"Koechlin","year":"2017","journal-title":"AIDS Behav"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0042","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review","volume":"37","author":"Mayer","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0043","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/cid\/ciz894","article-title":"Pre-exposure prophylaxis uptake and discontinuation among young black men who have sex with men in Atlanta, Georgia: a prospective cohort study","volume":"71","author":"Serota","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2025.03.001_bib0044","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/QAI.0000000000001497","article-title":"Challenges in translating PrEP interest into uptake in an observational study of young black MSM","volume":"76","author":"Rolle","year":"2017","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467925000952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467925000952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T04:58:27Z","timestamp":1762577907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467925000952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":41,"alternative-id":["S0736467925000952"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2025.03.001","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized Controlled Trial of HIV Pre-Exposure Prophylaxis Provision in the Emergency Department (PrEPPED)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2025.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}